These somatic alterations have been implicated in various processes central to plasma cell neoplasms, from chromatin remodeling (ARID1A, KMT2D, and BCL7A) to oncogenic signaling (PTPN11, NUP214). Here, PTPN11 is linked to plasma cell neoplasm.